ICU Medical(ICUI) - 2020 Q2 - Earnings Call Presentation

Revenue Performance (Q2 2020) - Total revenue decreased by 0% year-over-year (YoY) to $289 million[8], or increased by 1% on a constant currency basis[8] - Infusion Consumables revenue decreased by 6% YoY to $111 million[8], or decreased by 5% on a constant currency basis[8] - IV Solutions revenue decreased by 7% YoY to $74 million[8], both on a reported and constant currency basis[8] - Infusion Systems revenue increased by 12% YoY to $92 million[8], or increased by 15% on a constant currency basis[8] - Critical Care revenue increased by 14% YoY to $12 million[8], both on a reported and constant currency basis[8] Half Year (Six Months Ended June 30, 2020) Financials - GAAP net sales decreased from $312.282 million to $303.379 million[10] - Non-GAAP net sales decreased from $290.039 million to $289.041 million[10] - GAAP gross profit decreased from $103.869 million to $106.284 million[10] - Non-GAAP gross profit decreased from $122.056 million to $108.575 million[10] - GAAP Gross Profit % Sales increased from 33% to 35%[10] - Non-GAAP Gross Profit % of Non-GAAP Net Sales decreased from 42% to 38%[10]